跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PENTAXIM VACCINE - HSA Drug Approval Details
Approvals
/
HSA
/
PENTAXIM VACCINE
Approved
STANDARD
PENTAXIM VACCINE
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
f3069613da6e3b5b
Company
Unknown
Type
Standard
Approval Details
Approval Id
f3069613da6e3b5b
Drug Name
PENTAXIM VACCINE
Active Ingredients
(Vial) Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to Tetanus protein
10 μg/0.5 mL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
f3069613da6e3b5b
Type
Standard
Back to HSA Approvals